The antiarrhythmic effect of (-)-U-50,488 in rats with acute ischemia and reperfusion of heart is mediated by κ1-opioid receptor activation

Eksperimental'naya i Klinicheskaya Farmakologiya

Volumn 68, Issue 1, 2005, Pages 25-29

  Maslov, L N ^a,b   Lishmanov, A Yu ^a   Solenkova, N V ^a   Budankova, E V ^a   Crawford, D ^c   Wong, T M ^d   Chang, W C ^e   Bray, L X ^f  

^a CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

^b TOMSK STATE PEDAGOGICAL UNIVERSITY   (Russian Federation)

^c Langford House   (United Kingdom)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e Sanofi Synthelabo Inc   (United Kingdom)

^f GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 [(3,4 DICHLOROPHENYL)ACETYL] 3 (1 PYRROLIDINYLMETHYL) 1 PIPERAZINECARBOXYLIC ACID METHYL ESTER; ANTIARRHYTHMIC AGENT; KAPPA OPIATE RECEPTOR; KETAMINE; NORBINALTORPHIMINE; QUADAZOCINE; U 50 488;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; DRUG EFFECT; DRUG MECHANISM; ENANTIOMER; HEART MUSCLE ISCHEMIA; HEART PERFUSION; INCIDENCE; NONHUMAN; RAT; RECEPTOR AFFINITY; REPERFUSION;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARRHYTHMIA; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; NALTREXONE; NARCOTIC ANTAGONISTS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA;

EID: 15044358086     PISSN: 08692092     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. J.-S. Bian, W.-M. Zhang Q. Xia, and T. M. Wong, J. Mol. Cell. Cardiol., 30, 2103-2110 (1998).
2. P. J. Birch H. Rogers, A. G. Hayes, et al., Br. J. Pharmacol., 103, 1819-1823 (1991).
3. E. R. Butelman M. C. Ko, J. R. Traynor, et al., J. Pharmacol. Exp. Ther., 298(3), 1049-1059 (2001).
4. A. Cowan, X. Z. Zhu, H. I. Mosberg, et al., J. Pharmacol. Exp. Ther., 246(3), 950-955 (1988).
5. B. R. De Costa, W. D. Bowen, S. B. Hellewell, et al., J. Med. Chem., 32(8), 1996-2002 (1989).
6. P. J. Horan, B. R. De Costa K. Rice, et al., J. Pharmacol. Exp. Ther., 266(2), 926-933 (1993).
7. Yu. B. Lishmanov, L. N. Maslov, D. S. Ugdyzhekova, and G. N. Smagin, Life Sci., 61(3), PL33-PL38 (1997).
8. S. S. Negus, T. F. Burke, F. Medzihradsky, and J. H. Woods, J. Pharmacol. Exp. Ther., 267(2): 896-903 (1993).
9. M. K. Pugsley D. A. Saint, M. P. Penz, and M. J. Walker, Br. J. Pharmacol., 110(4), 1579-1585 (1993).
10. M. K. Pugsley D. A. Saint, and M. J. Walker, Eur. J. Pharmacol., 261(3), 303-309 (1994)
11. L. Rosenshtraukh, P. Danilo, E. P. Anyukhovskty, et al., Circ. Res., 75, 722-732 (1994).
12. The Cardiac Arrhythmia Supression Trial (CAST) Investigators. N. Engl. J. Med. (1989); 321, 406-412.
13. A. Van de Water, J. Verheyen, R. Xhonneux, and R. S. Reneman, J. Pharmacol. Methods, 22, 207-217 (1989).
14. T. M. Wong and S. Wu. Acta, Physiol. Sin., 55(2), 115-120 (2003).